Article Information
History
- June 6, 2021.
Article Versions
- Version 1 (January 9, 2021 - 18:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marisabel Rodriguez Messan1,
- Osman N. Yogurtcu1,
- Joseph R. McGill2,
- Ujwani Nukala1,
- Zuben E. Sauna2 and
- Hong Yang1,*
- 1Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, USA
- 2Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, USA
- ↵*Corresponding author: E-mail: Hong.Yang{at}fda.hhs.gov